After oncology experts reviewed arguments in favor of a surrogate endpoint to support multiple myeloma drug approvals, drug ...
Merck CEO Robert Davis has cracked the $20-million mark in annual pay for the first time, putting him in an exclusive club of ...
Eisai has added another strand to its budding podcast network, bankrolling the “Rethinking Alzheimer's Disease” miniseries to ...
After Lady Gaga shared her latest commercial for Pfizer’s migraine medication Nurtec ODT on Instagram earlier this week, many ...
Eight months after the European Medicines Agency (EMA) opened an investigation into a potential link between popular GLP-1 ...
History is repeating for AstraZeneca CEO Pascal Soriot, who successfully dodged an executive pay revolt at the company’s ...
After investigations into the FDA’s response to severe drug shortages and other issues, the House Committee on Oversight and ...
Geopolitical tensions are casting uncertainties over cross-border biotech deals. | Geopolitical tensions are casting ...
Just a few weeks after launching its Setting the P.A.C.E. initiative, Gilead Sciences is already picking up the tempo with a ...
As the contract manufacturing industry stands at a crossroads, certain CDMOs are prospering while other stalwarts are going ...
As it investigates a promising candidate to treat metabolic dysfunction-associated steatohepatitis (MASH), 89bio is laying ...
The U.S. government is accusing Regeneron of deliberately using an unusual method to overcharge Medicare for the company’s ...